EEFERP - USP / Laboratório de Fisiologia do Exercício e Metabolismo
Ribeirão Preto, São Paulo, Brazil
NCT Number: NCT05835401
Through a randomized, crossover, double-blind, placebo-controlled clinical trial, 20 bodybuilders will participate a acute-day trial with two intervention protocols: 1) placebo and 2) nitrate; in which will ingest beet juice with or without NO3 in its composition with a 7-day washout interval.
Looking for future studies?
Notify Me18 year–45 year
Male
Interventional
Not applicable
Ribeirão Preto, São Paulo, Brazil
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The participant will intake beetroot juice rich in NO3 (800mg). Two hours after intake the last bottle of juice, the participants will go to the laboratory for the handgrip and cardiovascular tests evaluation. Before crossover protocol a 7-day washout interval will be given for the purification of the compounds provided by the protocols.
The participant will intake beetroot juice depleted in NO3. Two hours after intake the last bottle of juice, the participants will go to the laboratory for the handgrip and cardiovascular tests evaluation. Before crossover protocol a 7-day washout interval will be given for the purification of the compounds provided by the protocols.
Time frame: up to 2 years
Time frame: up to 2 years
Time frame: up to 2 years
Time frame: up to 2 years
Time frame: up to 2 years
Time frame: up to 2 years
University of Sao Paulo
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06781853
Body Dysmorphic Disorder, Body Dysmorphic Disorder (BDD), Subtype: Muscle Dysmorphia
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05987891
Cardiovascular Abnormalities, Cardiovascular Diseases
São Paulo, Brazil
View Trial DetailsNCT05196815
Cardiovascular Abnormalities, Cardiovascular Diseases
Wolverhampton, West Midlands, United Kingdom
View Trial DetailsNCT05624255
Cardiovascular Abnormalities, Cardiovascular Diseases
Besançon, France
View Trial Details